Bumper Offer - Urjas oil Just @ Rs. 1
Glycovas Ld is a prescription drug, available for use as Tablet. It is typically used for the treatment of Diabetes. Other than this, Glycovas Ld has some other therapeutic uses, which have been discussed ahead.
The right dosage of Glycovas Ld depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Glycovas Ld include Stomach Upset, Difficulty urinating, Nasopharyngitis. Some other side effects of Glycovas Ld have been listed ahead. Usually, these side effects of Glycovas Ld go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Glycovas Ld is Severe for pregnant women and Mild for women who are breastfeeding. Warnings related to Glycovas Ld's effects on the liver, heart and kidney, if any, have been listed below.
Glycovas Ld is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. Other contraindications of Glycovas Ld have been discussed in the sections ahead.
Drug interactions for Glycovas Ld have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Glycovas Ld is considered safe while driving, and is addictive.
Glycovas Ld is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Glycovas Ld is used -
Severe
Moderate
Mild
Common
Is the use of Glycovas Ld safe for pregnant women?
Pregnant women may get severe side effects after taking Glycovas Ld. If you are pregnant, do not take Glycovas Ld without a doctor's advice.
Is the use of Glycovas Ld safe during breastfeeding?
Side effects of Glycovas Ld on breastfeeding women are very mild.
What is the effect of Glycovas Ld on the Kidneys?
There can be some harmful effects on your kidneys after taking Glycovas Ld. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glycovas Ld on the Liver?
The liver can be affected by Glycovas Ld. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Glycovas Ld only after medical advice.
What is the effect of Glycovas Ld on the Heart?
Glycovas Ld has very mild side effects on the heart.
Glycovas Ld should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glycovas Ld unless your doctor advises you to do so -
Is this Glycovas Ld habit forming or addictive?
No, you will not get addicted to Glycovas Ld.
Interaction between Food and Glycovas Ld
When consumed with certain foods, Glycovas Ld may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Glycovas Ld
Taking alcohol with Glycovas Ld can be dangerous.
Yes, Glycovas Ld is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
Yes, Glycovas Ld commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Glycovas Ld with your meal and increase the dose gradually.
Yes, Glycovas Ld can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Glycovas Ld causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Glycovas Ld may need to be adjusted.
Glycovas Ld is not a known cause of alopecia (hair loss). However, the conditions treated by Glycovas Ld type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, Glycovas Ld can cause some sleep problems, especially insomnia. On the other hand, Glycovas Ld has proven to be useful for preventing sleep apnea. The exact relationship between Glycovas Ld and sleep problems is still not clear, and further studies are needed for a clearer understanding.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
